Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.
Immune checkpoint inhibitors and their role in MM: pembrolizumab and durvalumab
Advances in multiple myeloma treatment over the last years
Ibrutinib and FCR chemoimmunotherapy: improving complete remission in CLL patients?
SWOG S0777 trial: lenalidomide, dexamethasone and bortezomib for the treatment of MM